Catalyst Pharmaceuticals, Inc.
CPRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $518 | $138 | $298 | $171 |
| Short-Term Investments | $0 | $0 | $0 | $20 |
| Receivables | $65 | $54 | $11 | $7 |
| Inventory | $20 | $16 | $7 | $8 |
| Other Curr. Assets | $21 | $13 | $5 | $4 |
| Total Curr. Assets | $624 | $219 | $321 | $210 |
| Property Plant & Equip (Net) | $4 | $4 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $157 | $194 | $32 | $0 |
| Long-Term Investments | $22 | $16 | $0 | $0 |
| Tax Assets | $46 | $37 | $19 | $24 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $228 | $251 | $55 | $28 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $851 | $470 | $376 | $238 |
| Liabilities | – | – | – | – |
| Payables | $17 | $15 | $4 | $3 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $1 | $1 | $9 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $103 | $60 | $45 | $24 |
| Total Curr. Liab. | $121 | $76 | $58 | $27 |
| LT Debt | $3 | $3 | $4 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $3 | $14 | $0 |
| Total NC Liab. | $3 | $6 | $18 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $4 | $4 | $4 |
| Total Liabilities | $124 | $82 | $75 | $31 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $285 | $121 | $50 | -$26 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $442 | $266 | $250 | $233 |
| Total Equity | $728 | $388 | $300 | $207 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $851 | $470 | $376 | $238 |
| Net Debt | -$514 | -$134 | -$295 | -$167 |